A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Conditions
Myelodysplastic Syndromes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
Contact: Principal Investigator (Andrew Artz)Los Angeles Cancer Network, Glendale, California, United States
Contact: Principal Investigator (Eric Lee)UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Principal Investigator (Amanda Kagan)Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States
Contact: Principal Investigator (Amer Zeidan)University of Miami Hospital and Clinics, Miami, Florida, United States
Contact: Principal Investigator (Mikkael Sekeres)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Rami Komrokji)ILCC. Illinois Cancer Centers, Peoria, Illinois, United States
Contact: Principal Investigator (Paul Fishkin)Norton Cancer Institute, Louisville, Kentucky, United States
Contact: Principal Investigator (Don Stevens)Maryland Oncology Hematolofy, Columbia, Maryland, United States
Contact: Principal Investigator (Mohit Narang)MidAmerica Cancer Care, Kansas City, Missouri, United States
Contact: Principal Investigator (Benjamin Fangman)Comprehensive Cancer Centers of Nevada, Henderson, Nevada, United States
Contact: Principal Investigator (Edwin Kingsley)Northwell Health, Lake Success, New York, United States
Contact: Principal Investigator (Bradley Goldberg)Clinical Research Alliance NY, Westbury, New York, United States
Contact: Principal Investigator (Jonathan Goldberg)Novant Health-Cancer Institute, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (James Dugan)Gabrail Cancer Center Research, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail)Cleveland Clinic - Cleveland, Cleveland, Ohio, United States
Contact: Principal Investigator (Akriti Jain)Tennessee Cancer Specialists, Knoxville, Tennessee, United States
Contact: Principal Investigator (Tracy Dobbs)Baptist Clinical Research Institute, Memphis, Tennessee, United States
Contact: Principal Investigator (Muhammad Raza)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Ashwin Kishtagari)Texas Oncology Northeast Texas, Denison, Texas, United States
Contact: Principal Investigator (Amir Faridi)U.T. MD Anderson Cancer Center, Division of Cancer Medicine, Houston, Texas, United States
Contact: Principal Investigator (Guillermo Garcia-Manero)Texas Oncology Gulf Coast, The Woodlands, Texas, United States
Contact: Principal Investigator (Andrew Jackson)Tranquil Research, Webster, Texas, United States
Contact: Principal Investigator (John Knecht)The Canberra Hospital, Garran, Australian Capital Territory, Australia
Contact: Principal Investigator (Philip Choi)Westmead Hospital, Sydney, New South Wales, Australia
Contact: Principal Investigator (Lachlin Vaughan)Townsville University Hospital, Douglas, Queensland, Australia
Contact: Principal Investigator (Joel Wight)Royal Adelaide Hospital, Adelaide, South Australia, Australia
Contact: Principal Investigator (Devendra Hiwase)Flinders Medical Centre, Adelaide, South Australia, Australia
Contact: Principal Investigator (David Beligaswatte)Box Hill Hospital, Box Hill, Victoria, Australia
Contact: Principal Investigator (Stephen Ting)St Vincent's Hospital (Melbourne) Ltd, Fitzroy, Victoria, Australia
Contact: Principal Investigator (ShuhYing Tan)Alfred Health, Melbourne, Victoria, Australia
Contact: Principal Investigator (Shaun Fleming)Peter MacCallum Cancer Center, Parkville, Victoria, Australia
Contact: Principal Investigator (Lynette Chee)Hosptial Erasto Gaertner, Curitiba, Paraná, Brazil
Contact: Principal Investigator (Eduardo Munhoz)Porto Alegre Clinical Hospital (HCPA), Porto Alegre, Rio Grande do Sul, Brazil
Contact: Principal Investigator (Laura Maria Fogliatto)Hospital Mae de Deus, Clinical Research Unit - Cancer Institute, Porto Alegre, Rio Grande do Sul, Brazil
Contact: Principal Investigator (Marcelo Capra)Pontifical University Of Rio Grande Do Sul (PUCRS) - St. Luke Hospital, Porto Alegre, Rio Grande do Sul, Brazil
Contact: Principal Investigator (Mariza Schaan)Instituto Joinvilense de Hematologia e Oncologia, Joinville, Santa Catarina, Brazil
Contact: Principal Investigator (Lacerda Marcelo)FundaAAo Doutor Amaral Carvalho, Jaú, São Paulo, Brazil
Contact: Principal Investigator (Guilherme Mattos)Cepho- Fmabc, Santo André, São Paulo, Brazil
Contact: Principal Investigator (Vitor Mauad)Sao Jose do Rio Preto Regional Faculty of Medicine Foundation, São José do Rio Preto, São Paulo, Brazil
Contact: Principal Investigator (Mariana Buka)Americas Institute, Rio de Janeiro, Brazil
Contact: Study coordinator (Site Contact) · fernandomonteiro@americasoncologia.com.br · 21-3385-2000Contact: Principal Investigator (Fernando Correia Pinto)Portuguese Charity of Sao Paulo, Clinical Hematology / Oncology Center, São Paulo, Brazil
Contact: Principal Investigator (Phillip Scheinberg)Hospital A.C.Camargo ("Antonio Prudente" Foundation), São Paulo, Brazil
Contact: Principal Investigator (Marina Nascimento)Santa Casa of Mercy of Santos, São Paulo, Brazil
Contact: Principal Investigator (Elaine Mancilha)Dr. Pencho Georgiev - Outpatient Center for Individual Practice for Specialized Medical Care in Internal Medicine and Clinical Hematology (EOOD), Plovdiv, Bulgaria
Contact: Principal Investigator (Pencho Georgiev)University Multiprofile Hospital for Active Treatment "Sveti Ivan Rilski", Sofia, Clinic of Clinical Hematology, Sofia, Bulgaria
Contact: Principal Investigator (Atanas Radinoff)Multiprofile Hospital for Active Treatment - Sofia, part of Military Medical Academy, Clinic of Hematology, Sofia, Bulgaria
Contact: Principal Investigator (Viktoria Barbukova)Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Clinic of Hematology, Sofia, Bulgaria
Contact: Principal Investigator (Tanya Yankova)University Multiprofile Hospital for Active Treatment "Sveta Marina", Clinic of Clinical Hematology, Varna, Bulgaria
Contact: Principal Investigator (Ilina Micheva)University of Alberta Hospital, Edmonton, Alberta, Canada
Contact: Principal Investigator (Nancy Zhu)Providence Hematology - Vancouver, Vancouver, British Columbia, Canada
Contact: Principal Investigator (Heather Leitch)Nova Scotia Health Authority, Centre for Clinical Research, Halifax, Nova Scotia, Canada
Contact: Principal Investigator (Amy Trottier)London Health Sciences Centre, London, Ontario, Canada
Contact: Principal Investigator (Lalit Saini)Sunnybrook Research Institute, Odette Cancer Center, Toronto, Ontario, Canada
Contact: Principal Investigator (Rena Buckstein)Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Karen Yee)Dr. Guillermo Grant Benavente - Concepcion Regional Hospital, Concepción, Biobio, Chile
Contact: Principal Investigator (Monica Romero)IC La Serena Research, La Serena, Coquimbo Region, Chile
Contact: Principal Investigator (Cleiden Villegas)SAGA Clinical Research Center SpA, Santiago, Chile
Contact: Principal Investigator (Ada Hernandez)Clinic Inmunocel, Santiago, Chile
Contact: Principal Investigator (Alejandro Berkovits)Center for Clinical Studies and Medical Research (CECIM), Santiago, Chile
Contact: Principal Investigator (Alexander Arellano)University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czechia
Contact: Principal Investigator (Jiri Mayer)University Hospital Hradec Kralove, 4th Internal Clinic of Hematology, Hradec Králové, Czechia
Contact: Principal Investigator (Petra Belohlavkova)University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czechia
Contact: Principal Investigator (Zdenek Koristek)University Hospital Kralovske Vinohrady, Clinic of Internal Hematology, Prague, Czechia
Contact: Principal Investigator (Olga Cerna)Institute of Hematology and Blood Transfusion, Division of Training and Development, Prague, Czechia
Contact: Principal Investigator (Marketa Stastna-Markova)Archet 1 and 2 hospital, Nice, France
Contact: Principal Investigator (Thomas Cluzeau)Saint-Louis Hospital, Paris, France
Contact: Principal Investigator (Lionel Ades)Poitiers University Hospital Center - Miletrie Site, Poitiers, France
Contact: Study coordinator (Site Contact) · Jose-Miguel.Torregrosa-Diaz@chu-poitiers.fr · +33 (5) 4944 5415Contact: Principal Investigator (Jose Miguel Torregrosa-Diaz)IUCT-Oncopole, Toulouse, France
Contact: Principal Investigator (Thibault Comont)University Hospital Bronn, Bonn, North Rhine-Westphalia, Germany
Contact: Principal Investigator (Karin Mayer)Marien Hospital Duesseldorf GmbH, Clinic for Oncology, Hematology and Palliative Medicine, Düsseldorf, North Rhine-Westphalia, Germany
Contact: Study coordinator (Site Contact) · Aristoteles.giagounidis@vkkd-kliniken.de · +49 (211) 4400 2501Contact: Principal Investigator (Aristoteles Giagounidis)University Hospital Leipzig, Clinic and Policlinic for Internal Medicine I Haematology and Stem Cell Therapy, Medical Oncology, Haemostaseology, Leipzig, Saxony, Germany
Contact: Principal Investigator (Dominic Brauer)University Hospital Halle (Saale), Department of Internal Medicine IV - Hematology and Oncology, Halle, Saxony-Anhalt, Germany
Contact: Principal Investigator (Haifa Al-Ali)University Clinic of Hematology, Oncology and Cell Therapy, Magdeburg, Saxony-Anhalt, Germany
Contact: Principal Investigator (Berisha Mirjeta)Praxis am Volkspark Berlin, Berlin, Germany
Contact: Study coordinator (Site Contact) · jp.habbel@praxis-am-volkspark-berlin.de · 49-30-84723535Contact: Principal Investigator (Jan-Piet Habbel)Charite Universitatsmedizin Berlin, Berlin, Germany
Contact: Principal Investigator (Kathrin Rieger)Semmelweis University, Department of Internal Medicine and Haematology, Division of Hematology, Budapest, Hungary
Contact: Principal Investigator (Zsolt Nagy)University of Debrecen Clinical Center, Clinic of Internal Medicine, Department of Hematology, Debrecen, Hungary
Contact: Principal Investigator (Arpad Illes)Mor Kaposi General Hospital, Department of Hematology, Kaposvár, Hungary
Contact: Principal Investigator (Miklos Egyed)Szabolcs-Szatmar-Bereg County Teaching Hospital, Department of Hematology, Nyíregyháza, Hungary
Contact: Principal Investigator (Laszlo Rejto)Fejer County St. Gyorgy University Teaching Hospital, Department of Internal Medicine III, Hematology, Székesfehérvár, Hungary
Contact: Principal Investigator (Arpad Szomor)Heamto Oncology Clinic Ahmedabad Pvt. Ltd., Ahmedabad, Gujarat, India
Contact: Principal Investigator (Sandip Shah)Apollo Hospital International Ltd, Ahmedabad, Gujarat, India
Contact: Principal Investigator (Velu Nair)Amrita Institute of Medical Sciences, Ernākulam, Kerala, India
Contact: Principal Investigator (Neeraj Siddharthan)Tata Memorial Centre, Mumbai, Maharashtra, India
Contact: Principal Investigator (Alok Shetty)Christian Medical College, Ludhianana, Ludhiana, Punjab, India
Contact: Principal Investigator (Joseph John)Christian Medical College, Vellore, Tamil Nadu, India
Contact: Principal Investigator (Biju George)Max Super Speciality Hospital Vaishali (A Unit Of Crosslay Remedies Ltd.), Ghaziabad, Uttar Pradesh, India
Contact: Principal Investigator (Pradeep Kumar)NRS Medical College and Hospital, Kolkata, West Bengal, India
Contact: Principal Investigator (Tuphan Kanti Dolai)Tata Medical Center, Kolkata, Kolkata, West Bengal, India
Contact: Principal Investigator (Arijit Nag)Postgraduate Institute of Medical Education and Research, Chandigarh, India
Contact: Principal Investigator (Pankaj Malhotra)Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India
Contact: Principal Investigator (Dinesh Bhurani)Medanta the Medicity, Gurgaon, India
Contact: Principal Investigator (Nitin Sood)Cork University Hospital, Cork, Ireland
Contact: Principal Investigator (Vitaliy Mykytiv)Beaumont Hospital, Dublin, Ireland
Contact: Principal Investigator (Philip Murphy)Mater Misericordiae University Hospital, Dublin, Ireland
Contact: Principal Investigator (Su Maung)Tallaght University Hospital, Dublin, Ireland
Contact: Principal Investigator (Helen Enright)St Vincent's University Hospital (SVUH), Dublin, Ireland
Contact: Principal Investigator (Claire Andrews)University Hospital Limerick, Limerick, Ireland
Contact: Principal Investigator (Cian McEllistrim)Hadassah Medical Center, Department of Hematology, Jerusalem, Israel
Contact: Principal Investigator (Revital Saban)Rabin Medical Center, Davidoff Cancer Center, Hemato-Oncology Institute, Petah Tikva, Israel
Contact: Principal Investigator (Ofir Wolach)Chaim Sheba Medical Center, Department of Hematology, Myelodysplastic Syndromes Center, Ramat Gan, Israel
Contact: Principal Investigator (Drorit Merkel)The Tel Aviv Sourasky Medical Center, Department of Hematology and Bone Marrow Transplantation, Leukemia Service, Tel Aviv, Israel
Contact: Principal Investigator (Yakir Moshe)Aou Delle Marche, Ancona, AN, Italy
Contact: Principal Investigator (Antonella Poloni)AO Ordine Mauriziano, Turin, Piedmont, Italy
Contact: Principal Investigator (Daniela Cilloni)Careggi University Hospital, Florence, Italy
Contact: Principal Investigator (Valeria Santini)Maggiore Polyclinic Hospital, Foundation IRCCS Ca' Granda, Milan, Italy
Contact: Principal Investigator (Bruno Fattizzo)Polyclinic San Matteo, IRCCS, Department of Oncohematology, Operative Unit of Hematology, Pavia, Italy
Contact: Principal Investigator (Luca Malcovati)Granda Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy
Contact: Principal Investigator (Caterina Alati)Foundation PTV - Polyclinic Tor Vergata, Rome, Italy
Contact: Principal Investigator (Maria Teresa Voso)Clinical Institute Humanitas, IRCCS, Rozzano, Italy
Contact: Principal Investigator (Matteo Giovanni Della Porta)Institute of Cancer Research and Treatment of Candiolo, Turin, Italy
Contact: Principal Investigator (Elena Crisa)Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania
Contact: Principal Investigator (Milda Rudzianskiene)Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
Contact: Principal Investigator (Andrius Degulys)Edgardo Rebagliati Martins National Hospital, Lima, Jesus Maria, Peru
Contact: Principal Investigator (Lourdes Aranda)Anglo American Clinic, Lima, La Molina, Peru
Contact: Principal Investigator (Antonio Carrasco)IPOR: Peruvian Institute of Oncology & Radiotherapy, Lima, San Isidro Lima, Peru
Contact: Principal Investigator (Maria Vera Vasquez)Daniel Alcides Carrion National Hospital, Bellavista, Peru
Contact: Principal Investigator (Jose Chinen Pemberton)National Institute of Neoplastic Diseases, Lima, Peru
Contact: Principal Investigator (Jule Vasquez)Pratia Poznan, Poznan, Greater, Poland
Contact: Principal Investigator (Anna Hoppe)Pratia Onkologia Wroclaw, Wroclaw, Lower Silesian Voivodeship, Poland
Contact: Principal Investigator (Justyna Rybka)Pratia Oncology Katowice, Katowice, Poland
Contact: Principal Investigator (Sebastian Grosicki)Nicolaus Copernicus Provincial Multispecialty Oncology and Traumatology Center in Lodz, General Hematology Unit, Lodz, Poland
Contact: Principal Investigator (Tadeusz Robak)Clinical Hospital Of The Ministry Of Internal Affairs And Administration With Warmia And Mazury Oncology Centre In Olsztyn, Clinical Department of Hematology and Internal Medicine with Bone Marrow Transplantation Center, Olsztyn, Poland
Contact: Principal Investigator (Janusz Halka)Haemalife, Cape Town, South Africa
Contact: Principal Investigator (Michael Cass)Capital Haematology Hospital, Durban, South Africa
Contact: Principal Investigator (Jaimendra Singh)Charlotte Maxeke Johannesburg Academic Hospital, Hemophilia Comprehensive Care Center, Johannesburg, South Africa
Contact: Principal Investigator (Johnny Mahlangu)Alberts Cellular Therapy, Pretoria, South Africa
Contact: Principal Investigator (Andrew McDonald)Kyungpook National University Hospital, Daegu, South Korea
Contact: Principal Investigator (Joon ho Moon)Seoul National University Hospital, Seoul, South Korea
Contact: Principal Investigator (Junshik Hong)Soon Chun Hyang University Hospital Seoul, Seoul, South Korea
Contact: Principal Investigator (Seug Yun Yoon)Asan Medical Center, Seoul, South Korea
Contact: Principal Investigator (Je-Hwan Lee)Samsung Medical Center, Seoul, South Korea
Contact: Principal Investigator (Jun Ho Jang)The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea
Contact: Principal Investigator (Yoo Jin Kim)University Clinical Hospital of Salamanca, Department of Hematology, Salamanca, Castille and León, Spain
Contact: Principal Investigator (Maria Diez Campelo)University Hospital Vall d'Hebron, Department of Hematology, Barcelona, Catalonia, Spain
Contact: Principal Investigator (David Valcarcel Ferreiras)Catalan Institute of Oncology, Hospital Duran i Reynals, Department of Clinical Hematology, L'Hospitalet de Llobregat, Girona, Spain
Contact: Principal Investigator (Montserrat Arnan Sangerman)University Hospital Ramon y Cajal, Madrid, Madrid, Spain
Contact: Principal Investigator (Kyra Velazquez Kennedy)University Hospital Foundation Jimenez Diaz, Madrid, Madrid, Spain
Contact: Principal Investigator (Teresa Arquero Portero)University and Polytechnic Hospital La Fe, Valencia, Valencia, Spain
Contact: Principal Investigator (Elvira Mora Castera)Karolinska University Hospital, Huddinge, Stockholm County, Sweden
Contact: Principal Investigator (Magnus Tobiasson)Sahlgrenska University Hospital, Gothenburg, VG, Sweden
Contact: Principal Investigator (Lena Von Bahr)Skane University Hospital - Lund, Department of Hematology and Vascular Disorders, Lund, Sweden
Contact: Principal Investigator (Lars Nilsson)A-rebro University Hospital, Hematology Department, Örebro, Örebro County, Sweden
Contact: Principal Investigator (Bengt Rasmussen)University Hosptial Basel, Basel, Canton of Basel-City, Switzerland
Contact: Principal Investigator (Gregor Stehle)Insel Gruppe AG, University Clinic for Hematology and Central Hematological Laboratory, Bern, Switzerland
Contact: Principal Investigator (Natalia Baran)Universitatsspital Zurich, Klinik fur Medizinische Onkologie und Hamatologie, Zurich, Switzerland
Contact: Principal Investigator (Stefan Balabanov)Changhua Christian Hospital, Changhua, Changhua County, Taiwan
Contact: Principal Investigator (Ruo-Han Tseng)Chang Bing Show Chwan Memorial Hospital, Changhua, Changhua County, Taiwan
Contact: Principal Investigator (Cheng-Shyong Chang)Taichung Veterans General Hospital, Taichung, Taiwan
Contact: Principal Investigator (Cheng-Hsien Lin)National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Principal Investigator (Tsai-Yun Chen)National Taiwan University Hospital, Taipei, Taiwan
Contact: Principal Investigator (Wen-Chien Chou)Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan
Contact: Principal Investigator (Ming-Chung Kuo)King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Contact: Principal Investigator (Noppacharn Uaprasert)Rajavithi Hospital, Bangkok, Thailand
Contact: Principal Investigator (Kunapa Iam-arunthai)Ramathibodi Hospital, Bangkok, Thailand
Contact: Principal Investigator (Piyajaroenkij Thanakrit)Banphaeo General Hospital, Bangkok, Thailand
Contact: Principal Investigator (Busakorn Sae-Aeng)Maharaj Nakorn Chiangmai Hospital, Chiang Mai, Thailand
Contact: Principal Investigator (Thanawat Rattanathammethee)Adana City Hospital, Adana, Turkey (Türkiye)
Contact: Principal Investigator (Elif Suyani)Ankara Etlik City Hospital, Ankara, Turkey (Türkiye)
Contact: Principal Investigator (Merih Kizil Cakar)Ankara University Medical Faculty Cebeci Hospital, Ankara, Turkey (Türkiye)
Contact: Principal Investigator (Selami Toprak)Antalya Education and Training Hospital, Antalya, Turkey (Türkiye)
Contact: Principal Investigator (Volkan Karakus)Mersin Medicalpark Hospital, Mersin, Turkey (Türkiye)
Contact: Principal Investigator (Anil Tombak)Sakarya University Medical Faculty Hospital, Sakarya, Turkey (Türkiye)
Contact: Principal Investigator (Cenk Sunu)Ondokuz Mayis University School of Medicine, Department of Hematology, Samsun, Turkey (Türkiye)
Contact: Principal Investigator (Engin Kelkitli)Aberdeen Royal Infirmary, Aberdeen, Aberdeen City, United Kingdom
Contact: Principal Investigator (Dominic Culligan)Glan Clwyd Hospital, Rhyl, Denbighshire, United Kingdom
Contact: Principal Investigator (Earnest Heartin)University Hospitals of Leicester, Leicester, Leics, United Kingdom
Contact: Principal Investigator (Matthew Lee)The Newcastle Upon Tyne University Hospitals Foundation Trust, High Heaton, Tyne and Wear, United Kingdom
Contact: Principal Investigator (Michelle Lannon)South Tyneside and Sunderland Foundation Trust, Sunderland, Tyne and Wear, United Kingdom
Contact: Principal Investigator (Scott Marshall)Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Contact: Principal Investigator (Vidhya Murthy)Addenbrooke's Hospital, Cambridge, United Kingdom
Contact: Principal Investigator (Duncan Brian)St James's University Hospital, Leeds, United Kingdom
Contact: Principal Investigator (Anjum Cargo)University College London Hospital, London, United Kingdom
Contact: Principal Investigator (Elspeth Payne)King's College Hospital, London, United Kingdom
Contact: Principal Investigator (Austin Kulasekararaj)Sarah Cannon Research Institute (SCRI), London, United Kingdom
Contact: Principal Investigator (Jennifer O'Sullivan (Dillon)The Christie NHS Foundation Trust, Manchester, United Kingdom
Contact: Principal Investigator (Daniel Wiseman)Nottingham City Hospital, Nottingham, United Kingdom
Contact: Principal Investigator (Jennifer Byrne)Churchill Hospital, Oxford, United Kingdom
Contact: Principal Investigator (Connor Chowdhury)
Study leads
Study Director
Takeda